Finding Hope with Clinical Trials: Q&A with Nick Slack Leave a Comment / Press / Joel E Finding Hope with Clinical Trials: Q&A with Nick Slack Read More »
The Undruggable Cancer Target: KRAS Inhibitors Move Ahead in the Clinic Leave a Comment / Press / Joel E The Undruggable Cancer Target: KRAS Inhibitors Move Ahead in the Clinic Read More »
CEO of START Reinforces the Importance of the Santa Maria Phase 1 Oncology Trial Center Leave a Comment / Press / Joel E CEO of START Reinforces the Importance of the Santa Maria Phase 1 Oncology Trial Center Read More »
The Connection Between Young Adults and Colon Cancer Leave a Comment / Press / Joel E The Connection Between Young Adults and Colon Cancer Read More »
Early Exposure & Site Network Support Enable PI’s Enduring Interest in Research Leave a Comment / Press / Joel E Early Exposure & Site Network Support Enable PI’s Enduring Interest in Research Read More »
First Patient Dosed with NILK-2301 in Phase I Clinical Trial Leave a Comment / Press / Joel E First Patient Dosed with NILK-2301 in Phase I Clinical Trial Read More »
NiKang Therapeutics Doses First Patient in a Phase 1/1b Study of NKT3447, an Oral, Selective Inhibitor of CDK2 Which Reduces Cyclin E Expression Leave a Comment / Press / Joel E NiKang Therapeutics Doses First Patient in a Phase 1/1b Study of NKT3447, an Oral, Selective Inhibitor of CDK2 Which Reduces Cyclin E Expression Read More »